| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = -$1,525 ) |
| | 2024 | 2021 | VALITOR, INC. | 2956 SAN PABLO AVE | BERKELEY | CA | 94702-2471 | ALAMEDA | USA | R43EY032414 | Antibody-hyaluronic acid bioconjugates for localized treatment of chronic non-infectious uveitis | 000 | 1 | NIH | 4/9/2024 | -$1,525 |
|
| Issue Date FY: 2023 ( Subtotal = $0 ) |
| | 2023 | 2018 | VALITOR, INC. | 2956 SAN PABLO AVE | BERKELEY | CA | 94702-2471 | ALAMEDA | USA | R43CA233108 | Bifunctional Protein-Polymer Bioconjugates for Localized Melanoma Immunotherapy | 000 | 1 | NIH | 11/23/2022 | $0 |
| | 2023 | 2018 | VALITOR, INC. | 2956 SAN PABLO AVE | BERKELEY | CA | 94702-2471 | ALAMEDA | USA | R43AR074368 | Anti-inflammatory bioconjugates for sustained inhibition of post-traumatic osteoarthritis following joint injury | 000 | 1 | NIH | 11/23/2022 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $6,611 ) |
| | 2022 | 2018 | VALITOR, INC. | 2956 SAN PABLO AVE | BERKELEY | CA | 94702-2471 | ALAMEDA | USA | R43AR074368 | Anti-inflammatory bioconjugates for sustained inhibition of post-traumatic osteoarthritis following joint injury | 000 | 1 | NIH | 10/23/2021 | -$252 |
| | 2022 | 2018 | VALITOR, INC. | 2956 SAN PABLO AVE | BERKELEY | CA | 94702-2471 | ALAMEDA | USA | R43CA233108 | Bifunctional Protein-Polymer Bioconjugates for Localized Melanoma Immunotherapy | 000 | 1 | NIH | 10/19/2021 | -$350 |
| | 2022 | 2017 | VALITOR, INC. | 2956 SAN PABLO AVE | BERKELEY | CA | 94702-2471 | ALAMEDA | USA | R43EY027229 | Multivalent Anti-VEGF Conjugates for Sustained Treatment of Diabetic Retinopathy | 000 | 1 | NIH | 9/26/2022 | $7,213 |
|
| Issue Date FY: 2021 ( Subtotal = $299,284 ) |
| | 2021 | 2021 | VALITOR, INC. | 820 HEINZ AVE | BERKELEY | CA | 94710-2737 | ALAMEDA | USA | R43EY032414 | Antibody-hyaluronic acid bioconjugates for localized treatment of chronic non-infectious uveitis | 000 | 1 | NIH | 6/11/2021 | $299,284 |
|
| Issue Date FY: 2020 ( Subtotal = $0 ) |
| | 2020 | 2018 | VALITOR, INC. | 820 HEINZ AVE | BERKELEY | CA | 94710-2737 | ALAMEDA | USA | R43CA233108 | Bifunctional Protein-Polymer Bioconjugates for Localized Melanoma Immunotherapy | 000 | 1 | NIH | 8/4/2020 | $0 |
| | 2020 | 2018 | VALITOR, INC. | 820 HEINZ AVE | BERKELEY | CA | 94710-2737 | ALAMEDA | USA | R43AR074368 | Anti-inflammatory bioconjugates for sustained inhibition of post-traumatic osteoarthritis following joint injury | 000 | 1 | NIH | 7/28/2020 | $0 |
| | 2020 | 2017 | VALITOR, INC. | 820 HEINZ AVE | BERKELEY | CA | 94710-2737 | ALAMEDA | USA | R43AR071857 | Long-acting anti-TNF? conjugates to minimize osteolysis around joint replacement devices | 000 | 1 | NIH | 1/14/2020 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $345,927 ) |
| | 2018 | 2018 | VALITOR, INC. | 820 HEINZ AVE | BERKELEY | CA | 94710-2737 | ALAMEDA | USA | R43AR074368 | Anti-inflammatory bioconjugates for sustained inhibition of post-traumatic osteoarthritis following joint injury | 000 | 1 | NIH | 9/11/2018 | $224,838 |
| | 2018 | 2018 | VALITOR, INC. | 820 HEINZ AVE | BERKELEY | CA | 94710-2737 | ALAMEDA | USA | R43CA233108 | Bifunctional Protein-Polymer Bioconjugates for Localized Melanoma Immunotherapy | 000 | 1 | NIH | 9/13/2018 | $298,864 |
| | 2018 | 2017 | VALITOR, INC. | 820 HEINZ AVE | BERKELEY | CA | 94710-2737 | ALAMEDA | USA | R43EY027229 | Multivalent Anti-VEGF Conjugates for Sustained Treatment of Diabetic Retinopathy | 000 | 1 | NIH | 8/27/2018 | -$12,747 |
| | 2018 | 2016 | VALITOR, INC. | 820 HEINZ AVE | BERKELEY | CA | 94710-2737 | ALAMEDA | USA | R43GM117976 | Multivalent protein-polymer conjugates to improve growth factor stability and therapeutic efficacy for wound healing | 000 | 1 | NIH | 9/6/2018 | -$26,095 |
| | 2018 | 2015 | VALITOR, INC. | 820 HEINZ AVE | BERKELEY | CA | 94710-2737 | ALAMEDA | USA | R44AR062418 | Multivalent Conjugates of Sonic Hedgehog to Accelerate Diabetic Wound Healing | 000 | 3 | NIH | 6/5/2018 | -$138,933 |
|
| Issue Date FY: 2017 ( Subtotal = $257,069 ) |
| | 2017 | 2017 | VALITOR, INC. | 820 HEINZ AVE | BERKELEY | CA | 94710-2737 | ALAMEDA | USA | R43EY027229 | Multivalent Anti-VEGF Conjugates for Sustained Treatment of Diabetic Retinopathy | 000 | 1 | NIH | 8/18/2017 | $32,135 |
| | 2017 | 2017 | VALITOR, INC. | 820 HEINZ AVE | BERKELEY | CA | 94710-2737 | ALAMEDA | USA | R43AR071857 | Long-acting anti-TNF? conjugates to minimize osteolysis around joint replacement devices | 000 | 1 | NIH | 9/12/2017 | $224,934 |
| | 2017 | 2015 | VALITOR, INC. | 820 HEINZ AVE | BERKELEY | CA | 94710-2737 | ALAMEDA | USA | R44AR062418 | Multivalent Conjugates of Sonic Hedgehog to Accelerate Diabetic Wound Healing | 001 | 3 | NIH | 3/27/2017 | $0 |
| | 2017 | 2014 | VALITOR, INC. | 820 HEINZ AVE | BERKELEY | CA | 94710-2737 | ALAMEDA | USA | R44AR062418 | Multivalent Conjugates of Sonic Hedgehog to Accelerate Diabetic Wound Healing | 000 | 2 | NIH | 1/14/2017 | $1,653 |
| | 2017 | 2012 | VALITOR, INC. | 820 HEINZ AVE | BERKELEY | CA | 94710-2737 | ALAMEDA | USA | R43AR062418 | Multivalent Conjugates of Sonic Hedgehog to Accelerate Diabetic Wound Healing | 000 | 1 | NIH | 1/14/2017 | -$1,653 |
|
| Issue Date FY: 2016 ( Subtotal = $570,545 ) |
| | 2016 | 2016 | VALITOR INC | 3841 COMPOLINDO DRIVE | MORAGA | CA | 94556 | CONTRA COSTA | USA | R43EY027229 | Multivalent Anti-VEGF Conjugates for Sustained Treatment of Diabetic Retinopathy | 000 | 1 | NIH | 9/8/2016 | $285,965 |
| | 2016 | 2016 | VALITOR INC | 3841 COMPOLINDO DRIVE | MORAGA | CA | 94556 | CONTRA COSTA | USA | R43GM117976 | Multivalent protein-polymer conjugates to improve growth factor stability and therapeutic efficacy for wound healing | 000 | 1 | NIH | 4/1/2016 | $284,580 |
|
| Issue Date FY: 2015 ( Subtotal = $782,937 ) |
| | 2015 | 2015 | VALITOR INC | 3841 COMPOLINDO DRIVE | MORAGA | CA | 94556 | CONTRA COSTA | USA | R44AR062418 | Multivalent Conjugates of Sonic Hedgehog to Accelerate Diabetic Wound Healing | 000 | 3 | NIH | 4/28/2015 | $782,937 |
| | 2015 | 2013 | VALITOR INC | 3841 COMPOLINDO DRIVE | MORAGA | CA | 94556 | CONTRA COSTA | USA | R43GM108272 | Multivalent Growth Factor Conjugates to Accelerate Wound Neovascularization in El | 000 | 1 | NIH | 8/6/2015 | $0 |
|
| Issue Date FY: 2014 ( Subtotal = $716,719 ) |
| | 2014 | 2014 | VALITOR INC | 3841 COMPOLINDO DRIVE | MORAGA | CA | 94556 | CONTRA COSTA | USA | R44AR062418 | Multivalent Conjugates of Sonic Hedgehog to Accelerate Diabetic Wound Healing | 000 | 2 | NIH | 5/1/2014 | $716,719 |
| | 2014 | 2012 | VALITOR INC | 3841 COMPOLINDO DRIVE | MORAGA | CA | 94556 | CONTRA COSTA | USA | R43AR062418 | Multivalent Conjugates of Sonic Hedgehog to Accelerate Diabetic Wound Healing | 000 | 1 | NIH | 5/1/2014 | $0 |
|
| Issue Date FY: 2013 ( Subtotal = $310,870 ) |
| | 2013 | 2013 | VALITOR INC | 3841 COMPOLINDO DRIVE | MORAGA | CA | 94556 | CONTRA COSTA | USA | R43GM108272 | Multivalent Growth Factor Conjugates to Accelerate Wound Neovascularization in El | 000 | 1 | NIH | 8/12/2013 | $310,870 |
|
| Issue Date FY: 2012 ( Subtotal = $311,158 ) |
| | 2012 | 2012 | VALITOR INC | 3841 COMPOLINDO DRIVE | MORAGA | CA | 94556 | CONTRA COSTA | USA | R43AR062418 | Multivalent Conjugates of Sonic Hedgehog to Accelerate Diabetic Wound Healing | 000 | 1 | NIH | 9/10/2012 | $311,158 |
|
|
